Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.120
-0.230 (-6.87%)
At close: Sep 26, 2025, 4:00 PM EDT
3.270
+0.150 (4.81%)
After-hours: Sep 26, 2025, 7:59 PM EDT

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $3.82M in the quarter ending June 30, 2025, a decrease of -5.77%. This brings the company's revenue in the last twelve months to $14.39M, up 2.65% year-over-year. In the year 2024, Vivos Therapeutics had annual revenue of $15.03M with 8.91% growth.

Revenue (ttm)
$14.39M
Revenue Growth
+2.65%
P/S Ratio
1.75
Revenue / Employee
$132,046
Employees
109
Market Cap
23.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202415.03M1.23M8.91%
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.